Dothiepin (therapeutic use) < Double-Blind Method < Down Syndrome (complications)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 260.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000020 (1999)	J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin	A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000050 (1999)	R. Ceravolo [Royaume-Uni] ; S. Salvetti ; P. Piccini ; C. Lucetti ; G. Gambaccini ; U. Bonuccelli	Acute and chronic effects of clozapine in essential tremor.
000061 (1999)	S A Factor [États-Unis] ; E S Molho	Transient benefit of amantadine in Parkinson's disease: the facts about the myth.
000132 (1999)	W C Koller [États-Unis] ; K E Lyons ; S B Wilkinson ; R. Pahwa	Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor.
000164 (1999)	G. Ebersbach [Autriche] ; M. Stöck ; J. Müller ; G. Wenning ; J. Wissel ; Werner Poewe [Autriche]	Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration.
000166 (1999)	T. Mezaki [Japon] ; R. Kaji ; M F Brin ; M. Hirota-Katayama ; T. Kubori ; T. Shimizu ; J. Kimura	Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
000190 (2000)	C. Ramaker [Pays-Bas] ; W J Van De Beek ; M J Finken ; B J Van Hilten	The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
000272 (2000)	R A Hauser [États-Unis] ; W C Koller ; J P Hubble ; T. Malapira ; K. Busenbark ; C W Olanow	Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
000274 (2000)	M D Welsh [États-Unis] ; E. Dorflinger ; D. Chernik ; C. Waters	Illness impact and adjustment to Parkinson's disease: before and after treatment with tolcapone.
000301 (2000)	R A Hauser [États-Unis] ; L. Gauger ; W M Anderson ; T A Zesiewicz	Pramipexole-induced somnolence and episodes of daytime sleep.
000304 (2000)	W. Ondo [États-Unis] ; C. Hunter ; K D Vuong ; K. Schwartz ; Joseph Jankovic [États-Unis]	Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.
000339 (2000)	E. Luginger [Autriche] ; G K Wenning ; S. Bösch ; Werner Poewe [Autriche]	Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease.
000401 (2000)	P J Van Wattum [États-Unis] ; P B Chappell ; D. Zelterman ; L D Scahill ; J F Leckman	Patterns of response to acute naloxone infusion in Tourette's syndrome.
000430 (2001)	S A Factor [États-Unis] ; J H Friedman ; M C Lannon ; D. Oakes ; K. Bourgeois	Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
000475 (2001)	F. Stocchi [Italie] ; L. Vacca ; A. Berardelli ; F. De Pandis ; S. Ruggieri	Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.
000503 (2001)	J T Hutton [États-Unis] ; L V Metman ; T N Chase ; J L Juncos ; W C Koller ; R. Pahwa ; P A Lewitt ; A. Samii ; J K Tsui ; D B Calne ; C H Waters ; V P Calabrese ; J P Bennett ; R. Barrett ; J L Morris	Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.
000512 (2001)	P. Del Dotto [Italie] ; N. Pavese ; G. Gambaccini ; S. Bernardini ; L V Metman ; T N Chase ; U. Bonuccelli	Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.
000582 (2001)	W. Koller [États-Unis] ; A. Lees ; M. Doder ; M. Hely	Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations.
000634 (2001)	B. Högl ; K. Seppi ; E. Brandauer ; G. Wenning ; Werner Poewe [Autriche]	Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.
000665 (2002)	Susan H. Fox [Royaume-Uni] ; Mark Kellett ; A Peter Moore ; Alan R. Crossman ; Jonathan M. Brotchie	Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia.
000719 (2002)	Christopher G. Goetz [États-Unis] ; Sue Leurgans ; Rema Raman	Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Double-Blind Method" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Double-Blind Method" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Double-Blind Method
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024